U
LOXO

UBS’s Loxo Oncology, Inc LOXO Stock Holding History

UBS’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$2K Buy
+155
New +$2.01K ﹤0.01% 10060

Other funds holding LOXO

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

UBS's LOXO Position: Q3 2014 in Review

UBS opened a new position in Loxo Oncology, Inc (LOXO) in Q3 2014: 155 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #10060 among its holdings.

35 funds tracked by Wall St. Rank hold LOXO as of Q3 2014.

  • UBS held 155 shares of Loxo Oncology, Inc worth $2K as of Q3 2014.
  • Loxo Oncology, Inc was a new UBS position in Q3 2014.
  • Loxo Oncology, Inc made up ﹤0.01% of UBS's portfolio in Q3 2014, its #10060 holding.
  • 35 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.